June 24-25, 2019
HealthTech Investor Days 2019
HealthTech Investor Days 2019 - Paris, France Genoscience Pharma was present during The HealthTech…
Read More
June 3, 2019
S.A.B Meeting in Chicago, during ASCO 2019
Scientific Advisory Board Meeting during ASCO 2019 Chicago, USA, June 3, 2019 — Genoscience…
Read More
April 17, 2019
Chaim Hurvitz, New Board of Directors Member
Chaim Hurvitz, New Board of Directors Member Chaim Hurvitz has joined Genoscience Pharma Board…
Read More
December 10, 2018
Most Innovative European Biotech SME for 2018
Most Innovative European Biotech SME for 2018 Bruxelles, Belgium, December 3, 2018 - Company…
Read More
October 5, 2018
Extension to US of GNS561 Clinical Trial
Genoscience Pharma Extends to US its Clinical Trial in Patients with Advanced Liver Cancers …
Read More
October 3-6, 2018
83èmes Journées Scientifiques de l’AFEF 2018
83èmes Journées Scientifiques de l'AFEF 2018 - Lyon , France During an amazing…
Read More
June 4, 2018
S.A.B. Meeting in Chicago, during ASCO 2018
Scientific Advisory Board Meeting during ASCO 2018 Chicago, USA, June 4, 2018 — During…
Read More
May 22, 2018
Extension to France of GN561 Clinical trial
Genoscience Pharma Extends its GNS561 Clinical Trial to France Enrollment is open for patients…
Read More
April 11-15, 2018
The EASL-International Liver Congress Meeting 2018
The EASL-International Liver Congress Meeting 2018 - Paris, France Genoscience Pharma was present…
Read More
April 5, 2018
First-in-human Dosing of GNS561 in Liver Cancer Patients
First-in-human Dosing of GNS561 in Patients with Advanced Liver Cancer at the Jules Bordet Institute,…
Read More
